170 related articles for article (PubMed ID: 37318257)
21. Inhibition of transforming growth factor beta signaling pathway promotes differentiation of human induced pluripotent stem cell-derived brain microvascular endothelial-like cells.
Yamashita M; Aoki H; Hashita T; Iwao T; Matsunaga T
Fluids Barriers CNS; 2020 May; 17(1):36. PubMed ID: 32456699
[TBL] [Abstract][Full Text] [Related]
22. Huntington's Disease iPSC-Derived Brain Microvascular Endothelial Cells Reveal WNT-Mediated Angiogenic and Blood-Brain Barrier Deficits.
Lim RG; Quan C; Reyes-Ortiz AM; Lutz SE; Kedaigle AJ; Gipson TA; Wu J; Vatine GD; Stocksdale J; Casale MS; Svendsen CN; Fraenkel E; Housman DE; Agalliu D; Thompson LM
Cell Rep; 2017 May; 19(7):1365-1377. PubMed ID: 28514657
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Glycogen Synthase Kinase 3ß Enhances Functions of Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells in the Blood-Brain Barrier.
Yamaguchi T; Nishijima M; Kawabata K
Biol Pharm Bull; 2022; 45(10):1525-1530. PubMed ID: 36184511
[TBL] [Abstract][Full Text] [Related]
24. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
[TBL] [Abstract][Full Text] [Related]
25. In vitro model of cerebral ischemia by using brain microvascular endothelial cells derived from human induced pluripotent stem cells.
Kokubu Y; Yamaguchi T; Kawabata K
Biochem Biophys Res Commun; 2017 Apr; 486(2):577-583. PubMed ID: 28336435
[TBL] [Abstract][Full Text] [Related]
26. Recent progress and new challenges in modeling of human pluripotent stem cell-derived blood-brain barrier.
Yan L; Moriarty RA; Stroka KM
Theranostics; 2021; 11(20):10148-10170. PubMed ID: 34815809
[TBL] [Abstract][Full Text] [Related]
27. Generation of an hiPSC-Derived Co-Culture System to Assess the Effects of Neuroinflammation on Blood-Brain Barrier Integrity.
Bull D; Schweitzer C; Bichsel C; Britschgi M; Gutbier S
Cells; 2022 Jan; 11(3):. PubMed ID: 35159229
[TBL] [Abstract][Full Text] [Related]
28. An hiPSC-Derived In Vitro Model of the Blood-Brain Barrier.
Goodwin-Trotman M; Patel K; Granata A
Methods Mol Biol; 2022; 2492():103-116. PubMed ID: 35733040
[TBL] [Abstract][Full Text] [Related]
29. Modeling and rescue of defective blood-brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients.
Lee CAA; Seo HS; Armien AG; Bates FS; Tolar J; Azarin SM
Fluids Barriers CNS; 2018 Apr; 15(1):9. PubMed ID: 29615068
[TBL] [Abstract][Full Text] [Related]
30. Modeling Group B
Kim BJ; Bee OB; McDonagh MA; Stebbins MJ; Palecek SP; Doran KS; Shusta EV
mSphere; 2017; 2(6):. PubMed ID: 29104935
[TBL] [Abstract][Full Text] [Related]
31. An isogenic neurovascular unit model comprised of human induced pluripotent stem cell-derived brain microvascular endothelial cells, pericytes, astrocytes, and neurons.
Canfield SG; Stebbins MJ; Faubion MG; Gastfriend BD; Palecek SP; Shusta EV
Fluids Barriers CNS; 2019 Aug; 16(1):25. PubMed ID: 31387594
[TBL] [Abstract][Full Text] [Related]
32. High and low permeability of human pluripotent stem cell-derived blood-brain barrier models depend on epithelial or endothelial features.
Girard SD; Julien-Gau I; Molino Y; Combes BF; Greetham L; Khrestchatisky M; Nivet E
FASEB J; 2023 Feb; 37(2):e22770. PubMed ID: 36688807
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood-Brain Barrier Model.
Clark PA; Al-Ahmad AJ; Qian T; Zhang RR; Wilson HK; Weichert JP; Palecek SP; Kuo JS; Shusta EV
Mol Pharm; 2016 Sep; 13(9):3341-9. PubMed ID: 27421304
[TBL] [Abstract][Full Text] [Related]
34. Defined Differentiation of Human Pluripotent Stem Cells to Brain Microvascular Endothelial-Like Cells for Modeling the Blood-Brain Barrier.
Foreman KL; Shusta EV; Palecek SP
Methods Mol Biol; 2023; 2683():113-133. PubMed ID: 37300771
[TBL] [Abstract][Full Text] [Related]
35. Differentiation and characterization of human pluripotent stem cell-derived brain microvascular endothelial cells.
Stebbins MJ; Wilson HK; Canfield SG; Qian T; Palecek SP; Shusta EV
Methods; 2016 May; 101():93-102. PubMed ID: 26518252
[TBL] [Abstract][Full Text] [Related]
36. Directed Differentiation of Human Induced Pluripotent Stem Cells to Heart Valve Cells.
Cai Z; Zhu M; Xu L; Wang Y; Xu Y; Yim WY; Cao H; Guo R; Qiu X; He X; Shi J; Qiao W; Dong N
Circulation; 2024 Apr; 149(18):1435-1456. PubMed ID: 38357822
[TBL] [Abstract][Full Text] [Related]
37. Influence of basal media composition on barrier fidelity within human pluripotent stem cell-derived blood-brain barrier models.
Neal EH; Katdare KA; Shi Y; Marinelli NA; Hagerla KA; Lippmann ES
J Neurochem; 2021 Dec; 159(6):980-991. PubMed ID: 34716922
[TBL] [Abstract][Full Text] [Related]
38. Chemically defined human vascular laminins for biologically relevant culture of hiPSC-derived brain microvascular endothelial cells.
Motallebnejad P; Azarin SM
Fluids Barriers CNS; 2020 Sep; 17(1):54. PubMed ID: 32912242
[TBL] [Abstract][Full Text] [Related]
39. Establishment of an in Vitro Human Blood-Brain Barrier Model Derived from Induced Pluripotent Stem Cells and Comparison to a Porcine Cell-Based System.
Di Marco A; Vignone D; Gonzalez Paz O; Fini I; Battista MR; Cellucci A; Bracacel E; Auciello G; Veneziano M; Khetarpal V; Rose M; Rosa A; Gloaguen I; Monteagudo E; Herbst T; Dominguez C; Muñoz-Sanjuán I
Cells; 2020 Apr; 9(4):. PubMed ID: 32316221
[TBL] [Abstract][Full Text] [Related]
40. Isogenic blood-brain barrier models based on patient-derived stem cells display inter-individual differences in cell maturation and functionality.
Patel R; Page S; Al-Ahmad AJ
J Neurochem; 2017 Jul; 142(1):74-88. PubMed ID: 28397247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
